A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2001
11/13/2001	US6315999 For prophylaxis and therapy of gram negative and gram positive bacteremia, septicemia and endotoxemia, as well as septic (or endotoxic) shock
11/13/2001	US6315998 Administering anti-cd40 monoclonal antibody or an antigen binding fragment which is being free of significant agonistic activity and binding to a human cd40 antigen located on surface of a human b cell prevents growth or differentiation
11/13/2001	US6315995 Adding to blood inactive recombinant mutein comprising proteolytically inactive mutein of factor ix or ixa to inhibit clot formation, does not interfere with hemostasis when the blood is administered to a patient
11/08/2001	WO2001083795A2 Particulate adenovirus, use thereof in vaccination
11/08/2001	WO2001083794A2 Dna transfection system for the generation of infectious influenza virus
11/08/2001	WO2001083785A2 Regulated antigen delivery system (rads) involving bacteria
11/08/2001	WO2001083783A2 In vivo loading of mhc
11/08/2001	WO2001083772A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	WO2001083757A1 Tt virus polypeptide, nucleic acid coding for said polypeptide and uses
11/08/2001	WO2001083750A2 Dendritic cell co-stimulator molecules
11/08/2001	WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	WO2001083744A2 Natrium-calcium exchanger protein
11/08/2001	WO2001083737A2 Porcine adenovirus type 5 vector and vaccine
11/08/2001	WO2001083721A2 32132, a novel fucosyltransferase family member and uses therefor
11/08/2001	WO2001083720A2 23686, a novel human aminotransferase and uses therefor
11/08/2001	WO2001083713A2 The use of tolerogenic dendritic cells for enhancing tolerogenicity in a host and methods for making the same
11/08/2001	WO2001083699A2 Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083561A2 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083555A2 Pain signaling molecules
11/08/2001	WO2001083553A2 G protein-coupled receptors
11/08/2001	WO2001083533A1 Helicobacter pylori antigens: fusion of hpaa and hpa44
11/08/2001	WO2001083532A1 Helicobacter pylori antigens: fusion of fay 31 and hpa 44
11/08/2001	WO2001083531A1 Method for identifying helicobacter antigens
11/08/2001	WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	WO2001083529A2 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083519A1 ANTIGENIC PEPTIDE FRAGMENTS OF VapA PROTEIN, AND USES THEREOF
11/08/2001	WO2001083385A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
11/08/2001	WO2001082966A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
11/08/2001	WO2001082965A1 Combination therapy of respiratory diseases using antibodies
11/08/2001	WO2001082964A1 Improved immunogenicity using a combination of dna and vaccinia virus vector vaccines
11/08/2001	WO2001082963A2 Method of identifying and producing antigen peptides and use thereof as vaccines
11/08/2001	WO2001082962A2 Immunizing against hiv infection
11/08/2001	WO2001082959A1 Omp protein associated with autologous and/or heterologous tumour cell lysate
11/08/2001	WO2001082958A2 Methods of producing membrane vesicles
11/08/2001	WO2001082957A1 Snthetic vaccine for tick control
11/08/2001	WO2001082948A2 Uses of tgap7 for the modulation of leucocyte activation
11/08/2001	WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	WO2001082900A1 Non-invasive gene targeting to the brain
11/08/2001	WO2001082897A2 Liposome drug delivery
11/08/2001	WO2001082788A2 Compounds and methods for the treatment and prevention of bacterial infection
11/08/2001	WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
11/08/2001	WO2001036485A3 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors
11/08/2001	WO2001034617A3 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
11/08/2001	WO2001034190A3 Live bacterial vaccines against escherichia coli o157:h7
11/08/2001	WO2001032697A3 Virulence genes and proteins from brucella melitensis, and their use
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001030383A3 Medicament in order to induce tolerance
11/08/2001	WO2001026680A3 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells
11/08/2001	WO2001023414A3 Immunologically significant herpes simplex virus antigens
11/08/2001	WO2001019958A3 Stabilized soluble glycoprotein trimers
11/08/2001	WO2001018035A3 Muc-1 derived peptides
11/08/2001	WO2001008707A3 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/08/2001	WO2000069897A3 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/08/2001	US20010039669 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
11/08/2001	US20010039258 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and to form a subcutaneously deliverable supramolecular complex, subcutaneously administering complex
11/08/2001	US20010039038 Novel glucosaminidase
11/08/2001	US20010039027 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
11/08/2001	US20010039017 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/08/2001	US20010039016 Measurement, calibration gene expression
11/08/2001	US20010039008 Immunofluorescence
11/08/2001	US20010038859 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
11/08/2001	US20010038844 Comprising an avirulent Salmonella strain expressing a Campylobacter antigen
11/08/2001	US20010038843 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies
11/08/2001	US20010038842 Treating a disease characterized by expression of vascular endothelial growth factor-D (VEGF-D) by a tumor by screening for a VEGF-D expressing tumor, administering a VEGF-D antagonist to prevent binding of VEGF-D to its receptor
11/08/2001	US20010038841 Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
11/08/2001	US20010038840 Method for the treatment of fibrosis
11/08/2001	US20010038832 Administering an effective amount interferon-gamma and a sensitizing agent selected from atlest nitrogen oxide, nitrogen oxide synthase type II (iNOS) nitrogen oxide donar and nitrogen oxide mimics for treating cancer
11/08/2001	CA2750984A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2712368A1 Dna transfection system for the generation of infectious influenza virus
11/08/2001	CA2420287A1 Anthrax specific antibodies
11/08/2001	CA2416725A1 Immunizing against hiv infection
11/08/2001	CA2413265A1 Porcine adenovirus type 5 vector and vaccine
11/08/2001	CA2409689A1 Combination therapy of respiratory diseases using antibodies
11/08/2001	CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	CA2407946A1 Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
11/08/2001	CA2407887A1 Natrium-calcium exchanger protein
11/08/2001	CA2407709A1 Regulated antigen delivery system (rads) involving bacteria
11/08/2001	CA2407700A1 Compositions and methods for inducing activation of dendritic cells
11/08/2001	CA2407604A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2407443A1 Compounds and methods for the treatment and prevention of bacterial infection
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407426A1 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	CA2407303A1 Improved immunogenicity using a combination of dna and vaccinia virus vector vaccines
11/08/2001	CA2407292A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
11/08/2001	CA2407225A1 Methods of producing membrane vesicles
11/08/2001	CA2407219A1 Pain signaling molecules
11/08/2001	CA2407068A1 Antigenic peptide fragments of vapa protein, and uses thereof
11/08/2001	CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	CA2406746A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	CA2405363A1 Epitope synchronization in antigen presenting cells
11/07/2001	EP1152243A1 DIagnosis of Sjögren's syndrome, systemic lupus erythematosis, and scleroderma via detection of anti-retroviral antibodies
11/07/2001	EP1152061A1 Development of method for screening physiologically active pyrrole imidazole derivative
11/07/2001	EP1152060A1 5T4 tumour-associated antigen for use in tumour immunotherapy
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1152012A1 Tuberculosis vaccine and peptides
11/07/2001	EP1151756A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus

1 ... 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 ... 1823